The association between protein truncating variants in BRIP1 and risk of ovarian cancer has been confirmed in other analyses (associated risks ranged from 2.6 to 6.4 [27,28,29,35,45]) (Table 2 and Table 3). Here, BRIP1 is linked to ovarian carcinoma.